Last reviewed · How we verify

NCT07140107

Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews

ENROLLING BY INVITATION NA Last updated 24 August 2025
What this trial tests

NA trial testing AI-generated PLS in Non-Metastatic Breast Cancer in 130 participants. Enrolling by invitation.

Timeline
14 August 2025
Primary endpoint
1 February 2026
1 February 2026

Quick facts

Lead sponsorUniversity of Split, School of Medicine
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment130
Start date14 August 2025
Primary completion1 February 2026
Estimated completion1 February 2026
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

University of Split, School of Medicine

Who can join

18 and older, female only, with Non-Metastatic Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study explores how patients with non-metastatic breast cancer perceive and comprehend original Plain Language Summary and AI-generated Plain Language Summary (PLS) of two systematic reviews from the Cochrane Library. The systematic reviews address exercise during adjuvant therapy and psychological interventions for non-metastatic breast cancer. The study, which is randomized and double-blind, aims to assess whether AI-generated PLS and original PLS differ in their influence on patients' intention to undertake and apply the recommendation presented in the summary, as well as their overall understanding of the study results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Split, School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07140107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing